AS Latvijas Juras medicinas centrs (ORSE:LJM1R) PB Ratio: 0.99 (As of Jul. 12, 2026) — Near Median


ORSE:LJM1R AS Latvijas Juras medicinas centrs ORSE:LJM1R
59 GF Score
Price €7.80
GF Value €7.78
! 3 Warning Signs
View Full Analysis

What is AS Latvijas Juras medicinas centrs PB Ratio?

AS Latvijas Juras medicinas centrs ORSE:LJM1R 59 PB Ratio is 0.99 as of Jul. 12, 2026, which is at its 10-year median of 0.99. GuruFocus rates ORSE:LJM1R with a GF Score™ of 59/100 and a GF Value™ of €7.78. The stock has 3 warning signs investors should review.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), AS Latvijas Juras medicinas centrs's share price is €7.80. AS Latvijas Juras medicinas centrs's Book Value per Share for the quarter that ended in Dec. 2025 was €7.91. Hence, AS Latvijas Juras medicinas centrs's PB Ratio of today is 0.99.

The historical rank and industry rank for AS Latvijas Juras medicinas centrs's PB Ratio or its related term are showing as below:

ORSE:LJM1R' s PB Ratio Range Over the Past 10 Years
Min: 0.29   Med: 0.99   Max: 2.1
Current: 0.99

During the past 13 years, AS Latvijas Juras medicinas centrs's highest PB Ratio was 2.10. The lowest was 0.29. And the median was 0.99.

ORSE:LJM1R's PB Ratio is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 2.01 vs ORSE:LJM1R: 0.99

During the past 12 months, AS Latvijas Juras medicinas centrs's average Book Value Per Share Growth Rate was 2.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -2.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 1.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 0.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of AS Latvijas Juras medicinas centrs was 57.50% per year. The lowest was -14.60% per year. And the median was -1.95% per year.

Back to Basics: PB Ratio


AS Latvijas Juras medicinas centrs  (ORSE:LJM1R) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


AS Latvijas Juras medicinas centrs PB Ratio Related Terms


AS Latvijas Juras medicinas centrs PB Ratio Historical Data

* Premium members only.

The historical data trend for AS Latvijas Juras medicinas centrs's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AS Latvijas Juras medicinas centrs PB Ratio Chart

AS Latvijas Juras medicinas centrs Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 1.38 1.28 0.84 1.13

AS Latvijas Juras medicinas centrs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.80 0.85 0.80 1.13

ORSE:LJM1R vs HCA, THC, ENSG: PB Ratio Comparison

For the Medical Care Facilities subindustry, AS Latvijas Juras medicinas centrs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AS Latvijas Juras medicinas centrs PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AS Latvijas Juras medicinas centrs's PB Ratio distribution charts can be found below:

* The bar in red indicates where AS Latvijas Juras medicinas centrs's PB Ratio falls into.


ORSE:LJM1R
59GF Score
AS Latvijas Juras medicinas centrs ORSE:LJM1R
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AS Latvijas Juras medicinas centrs PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

AS Latvijas Juras medicinas centrs's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=7.80/7.908
=0.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 0.99 mean?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a PB Ratio of 0.99 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on AS Latvijas Juras medicinas centrs and its competitors. This is near median its historical median of 0.99. Over the past decade, AS Latvijas Juras medicinas centrs' PB Ratio has ranged from 0.29 to 2.10.
Is AS Latvijas Juras medicinas centrs' PB Ratio too high?
AS Latvijas Juras medicinas centrs' current PB Ratio of 0.99 is near median its 10-year median of 0.99. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 2.10. The Healthcare Providers & Services industry median PB Ratio is 2.01. AS Latvijas Juras medicinas centrs' value of 0.99 is 50.7% below this industry median. Overall, AS Latvijas Juras medicinas centrs has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does AS Latvijas Juras medicinas centrs' PB Ratio compare to HCA and THC?
AS Latvijas Juras medicinas centrs' PB Ratio of 0.99 can be compared against companies in the Healthcare Providers & Services industry. The industry median PB Ratio is 2.01. AS Latvijas Juras medicinas centrs' value of 0.99 is 50.7% below this benchmark. Historically, AS Latvijas Juras medicinas centrs' own PB Ratio has ranged from 0.29 to 2.10 over the past decade. While the company's 10-year median is 0.99 vs. the industry median of 2.01, AS Latvijas Juras medicinas centrs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.01, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AS Latvijas Juras medicinas centrs's current PB Ratio of 0.99 is 50.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on AS Latvijas Juras medicinas centrs and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AS Latvijas Juras medicinas centrs's current PB Ratio is 0.99, which is near median its own 10-year median of 0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AS Latvijas Juras medicinas centrs stock overvalued right now?
AS Latvijas Juras medicinas centrs (ORSE:LJM1R) has a current PB Ratio of 0.99. The stock's GF Value™ is €7.78, compared to a current price of €7.80 — trading 0.3% above its estimated fair value. The current PB Ratio is 0.99, which is near median its 10-year median of 0.99 and 50.7% below the Healthcare Providers & Services industry median of 2.01. AS Latvijas Juras medicinas centrs' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For AS Latvijas Juras medicinas centrs (ORSE:LJM1R), the current PB Ratio is 0.99 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Overvalued in 2026?

Based on GuruFocus' analysis, AS Latvijas Juras medicinas centrs stock appears to be overvalued. The current stock price of €7.80 is trading 0.3% above its estimated GF Value™ of €7.78.

Key valuation signals for ORSE:LJM1R:

  • PB Ratio: 0.99 (near median its 10-year median of 0.99)
  • GF Value™: €7.78 vs. price of €7.80 (0.3% above fair value)
  • GF Score™: 59/100 with 3 warning signs
  • Industry Position: 50.7% below the Healthcare Providers & Services median

No single metric tells the full story. See the ORSE:LJM1R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AS Latvijas Juras medicinas centrs Business Description

Address Patversmes iela 23, Riga, LVA, LV-1005
AS Latvijas Juras medicinas centrs is a private certified medical institution in Latvia providing outpatient and inpatient healthcare services through qualified staff and modern equipment. Its core activities include hospital services, orthopaedic retail, medical and dental practice, human health and residential care, social work activities, and physical well-being services. It operates the Women's Health Clinic, offering gynecological consultations, pregnancy care, diagnostics, postpartum services, gynecological care for girls, and surgery. The centre also provides vaccination, rehabilitation, a Multiple Sclerosis Center, medical commission, home visits, laboratory services, physical medicine and massage, therapeutic procedures, medical treatment, and anesthesia and intensive care.
59GF Score

Get the complete analysis for ORSE:LJM1R

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.80
Price
€7.78
GF Value